Andreas Hilgeroth

1.9k total citations
110 papers, 1.5k citations indexed

About

Andreas Hilgeroth is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Andreas Hilgeroth has authored 110 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Organic Chemistry, 58 papers in Molecular Biology and 42 papers in Oncology. Recurrent topics in Andreas Hilgeroth's work include Drug Transport and Resistance Mechanisms (32 papers), HIV/AIDS drug development and treatment (27 papers) and Cancer therapeutics and mechanisms (24 papers). Andreas Hilgeroth is often cited by papers focused on Drug Transport and Resistance Mechanisms (32 papers), HIV/AIDS drug development and treatment (27 papers) and Cancer therapeutics and mechanisms (24 papers). Andreas Hilgeroth collaborates with scholars based in Germany, Hungary and South Korea. Andreas Hilgeroth's co-authors include Hauke Lilie, Ute Baumeister, Hermann Lage, Christoph Schächtele, Frank Totzke, B. VOIGT, Mardia T. El Sayed, Frank W. Heinemann, Andreas Billich and Wolfgang Sippl and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Andreas Hilgeroth

105 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Hilgeroth Germany 22 831 615 364 169 156 110 1.5k
Jay Wrobel United States 33 1.5k 1.8× 876 1.4× 410 1.1× 150 0.9× 177 1.1× 76 2.8k
Liying Ma China 29 778 0.9× 1.3k 2.1× 488 1.3× 119 0.7× 87 0.6× 89 2.2k
Daniel Dauzonne France 22 585 0.7× 862 1.4× 275 0.8× 110 0.7× 135 0.9× 70 1.7k
Ji‐Wang Chern Taiwan 26 1.1k 1.3× 1.2k 1.9× 312 0.9× 101 0.6× 157 1.0× 116 2.2k
Marco L. Lolli Italy 22 386 0.5× 563 0.9× 76 0.2× 152 0.9× 116 0.7× 67 1.2k
Stephen W. Kaldor United States 20 1.4k 1.6× 1.2k 2.0× 310 0.9× 422 2.5× 112 0.7× 36 2.6k
Doo-Man Oh United States 4 284 0.3× 588 1.0× 186 0.5× 116 0.7× 78 0.5× 6 1.3k
Kunal Nepali Taiwan 24 895 1.1× 1.0k 1.7× 270 0.7× 64 0.4× 205 1.3× 66 2.1k
Maria M. M. Santos Portugal 27 1.3k 1.6× 731 1.2× 370 1.0× 53 0.3× 94 0.6× 71 2.1k

Countries citing papers authored by Andreas Hilgeroth

Since Specialization
Citations

This map shows the geographic impact of Andreas Hilgeroth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hilgeroth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hilgeroth more than expected).

Fields of papers citing papers by Andreas Hilgeroth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hilgeroth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hilgeroth. The network helps show where Andreas Hilgeroth may publish in the future.

Co-authorship network of co-authors of Andreas Hilgeroth

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Hilgeroth. A scholar is included among the top collaborators of Andreas Hilgeroth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Hilgeroth. Andreas Hilgeroth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krüger, Thomas, Abdulkarim Najjar, Frank Totzke, et al.. (2017). Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(12). 2708–2712. 18 indexed citations
2.
Hilbrich, Isabel, et al.. (2016). Drug Development of Small-Molecule Inhibitors of AD-Relevant Kinases as Novel Perspective Multitargeted Approach. Current Alzheimer Research. 13(12). 1330–1336. 8 indexed citations
3.
Sayed, Mardia T. El, et al.. (2014). Novel Aspects of Domino Reaction of Indoles with Homo- Phthalaldehyde and Tere-phthalaldehyde. Global Journal of Human Social Science. 14(6). 1 indexed citations
4.
Schächtele, Christoph, et al.. (2014). Discovery of 4-anilino α-carbolines as novel Brk inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(8). 1948–1951. 21 indexed citations
5.
6.
Hilgeroth, Andreas, et al.. (2012). The Impact of the Induction of Multidrug Resistance Transporters in Therapies by Used Drugs: Recent Studies. Mini-Reviews in Medicinal Chemistry. 12(11). 1127–1134. 16 indexed citations
7.
8.
Lage, Hermann, et al.. (2010). Novel structure–activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators. Bioorganic & Medicinal Chemistry. 18(14). 4983–4990. 29 indexed citations
9.
Lage, Hermann, et al.. (2008). Impact of Novel MDR Modulators on Human Cancer Cells: Reversal Activities and Induction Studies. Pharmaceutical Research. 26(1). 182–188. 12 indexed citations
10.
Hilgeroth, Andreas, et al.. (2008). Recent Advances in the Development of Multi-Kinase Inhibitors. Mini-Reviews in Medicinal Chemistry. 8(13). 1312–1327. 81 indexed citations
11.
Duarte, Noélia, et al.. (2008). Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells. Bioorganic & Medicinal Chemistry. 16(20). 9323–9330. 30 indexed citations
12.
Molnár, József, et al.. (2006). Physicochemical Characteristics Of Novel P-Glycoprotein Inhibitors Of The Cage Dimeric 1,4-Dihydropyridine Type. Medicinal Chemistry. 2(6). 565–568. 1 indexed citations
13.
Richter, Martin, et al.. (2005). First Insight into the Symmetry and Flexibility of Membrane Efflux Pump P‐Glycoprotein by Novel Bifunctional Modulators. ChemBioChem. 6(8). 1353–1356. 4 indexed citations
14.
VOIGT, B., Laurent Meijer, Olivier Lozach, et al.. (2004). Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenes. Bioorganic & Medicinal Chemistry Letters. 15(3). 823–825. 39 indexed citations
15.
Richter, Martin, et al.. (2004). Comparative Effects on Intestinal Absorption in Situ by P-glycoprotein-Modifying HIV Protease Inhibitors. Pharmaceutical Research. 21(10). 1862–1866. 10 indexed citations
16.
Hilgeroth, Andreas & Hauke Lilie. (2003). Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors. European Journal of Medicinal Chemistry. 38(5). 495–499. 80 indexed citations
17.
18.
Hilgeroth, Andreas, et al.. (2002). Synthesis and first biological evaluation of 1-aza-9-oxafluorenes as novel lead structures for the development of small-sized cytostatics. Bioorganic & Medicinal Chemistry Letters. 12(3). 411–413. 12 indexed citations
19.
Hilgeroth, Andreas. (1998). HIV‐1 Protease‐Inhibitoren im Überblick. Pharmazie in unserer Zeit. 27(1). 22–25. 6 indexed citations
20.
Hilgeroth, Andreas. (1998). Neue Nucleosidanaloga zur Therapie viraler Erkrankungen im Überblick. Pharmazie in unserer Zeit. 27(3). 111–116. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay Wrobel Breakdown of academic impact, for papers by Liying Ma Breakdown of academic impact, for papers by Daniel Dauzonne Breakdown of academic impact, for papers by Ji‐Wang Chern Breakdown of academic impact, for papers by Marco L. Lolli Breakdown of academic impact, for papers by Stephen W. Kaldor Breakdown of academic impact, for papers by Doo-Man Oh Breakdown of academic impact, for papers by Kunal Nepali Breakdown of academic impact, for papers by Maria M. M. Santos
Rankless by CCL
2026